MICU1-Related Myopathy with Extrapyramidal Signs (MPXPS): A Patient Guide
At a Glance
MPXPS is a rare MICU1-related genetic disorder that commonly causes persistent muscle weakness, fatigue, and high creatine kinase levels, while movement symptoms vary. There is no cure yet, but tailored therapies and careful anesthesia planning support safety and daily function.
Receiving a diagnosis of a rare genetic disorder is life-changing, and it is completely normal to feel overwhelmed by the medical terminology. MICU1-Related Myopathy with Extrapyramidal Signs (MPXPS) is an exceptionally rare condition that affects how the “power plants” of the cells, the mitochondria, manage energy.
In a healthy cell, the MICU1 protein acts as a gatekeeper, helping to regulate calcium entering the mitochondria to boost energy production. When this protein is missing or non-functional, the mitochondria lose their ability to regulate this flow. Research in models suggests this leads to a state of cellular stress that primarily impacts the muscles and the brain [1][2].
While the condition’s name includes “Extrapyramidal Signs”—which refers to movement disorders like chorea or dystonia—the way the disease looks is highly variable. Most children experience persistent muscle weakness and tire much more easily than their peers, but roughly half of reported patients do not develop these movement issues [3][4]. This variability means that two children with the exact same genetic change can have very different daily experiences, with symptoms ranging from mild fatigue to more significant physical and learning challenges [3][5].
A hallmark of this condition that often leads to its discovery is a persistently elevated level of creatine kinase (CK) in the blood. This enzyme leaks from muscle cells when they are under stress, serving as a biological marker even when weakness is mild. Because MPXPS is so rare, many families spend years searching for an answer before genetic testing finally identifies the MICU1 variant. While there is currently no cure, a dedicated team of specialists can help manage symptoms through individualized physical, occupational, and speech therapies tailored to your child’s specific needs [5][6].
Living with MPXPS also requires a proactive approach to safety, particularly regarding medical procedures. Because the muscles are uniquely sensitive, specific medications used in anesthesia, such as succinylcholine, must be strictly avoided to prevent serious complications [7]. By building a knowledgeable care team and securing an individualized emergency and anesthesia plan, you can help ensure your child navigates both daily life and medical challenges safely. While the long-term course remains uncertain, focusing on supportive care and symptom management can help your child maximize their function and well-being [7][8].
In this guide
6 chapters
Understanding MPXPS: MICU1-Related Myopathy
Learn about MICU1-related MPXPS, including its mitochondrial cause, muscle weakness, high CK levels, movement signs, inheritance, outlook, and supportive care.
Symptoms and Disease Behavior
Learn about MICU1-related MPXPS symptoms in children, including muscle weakness, fatigue, movement changes, learning difficulties, and variable progression.
How MICU1 Works and Ruling Out Other Conditions
Learn how MICU1-related MPXPS affects mitochondrial calcium control and how genetic tests help distinguish it from treatable mimics and similar muscle disorders.
Diagnostic Testing and Interpreting Results
Learn how MICU1-related MPXPS is diagnosed using CK and AST/ALT tests, muscle MRI, EMG, and genetic testing, including what VUS and inheritance results mean.
Standard Care and Building the Care Team
Learn how MICU1-related MPXPS is managed with supportive care, a multidisciplinary team, fatigue strategies, swallowing checks and specialist visit preparation.
Monitoring, Anesthesia Risks, and Emergencies
Learn how MICU1-related MPXPS affects anesthesia safety, emergency warning signs, sick-day planning, and long-term monitoring for children and families.
Common questions in this guide
What is MICU1-related myopathy with extrapyramidal signs?
What symptoms can a child with MPXPS develop?
How is MPXPS diagnosed?
Is there a cure or treatment for MPXPS?
What anesthesia precautions are needed for a child with MPXPS?
How can families coordinate school, therapy, and daily care for MPXPS?
Get notified when new evidence is published on Proximal myopathy with extrapyramidal signs.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (8)
- 1
Molecular pathophysiology of human MICU1 deficiency.
Kohlschmidt N, Elbracht M, Czech A, et al.
Neuropathology and applied neurobiology 2021; (47(6)):840-855 doi:10.1111/nan.12694.
PMID: 33428302 - 2
A Middle Eastern Founder Mutation Expands the Genotypic and Phenotypic Spectrum of Mitochondrial MICU1 Deficiency: A Report of 13 Patients.
Musa S, Eyaid W, Kamer K, et al.
JIMD reports 2019; (43()):79-83 doi:10.1007/8904_2018_107.
PMID: 29721912 - 3
Bi-Allelic Variants in MICU1 Cause Myopathy With Extrapyramidal Signs: Case Series, Phenotypic Spectrum, and Genotype-Phenotype Correlations From 61 Patients.
Beheshti P, Akbarian F, Esmaeilzadeh E, et al.
Clinical genetics 2026; (109(3)):564-570 doi:10.1111/cge.70062.
PMID: 40898676 - 4
MICU1 related myopathy - a rare report from India.
Baskar D, Ganji SR, Thomas A, et al.
Journal of neuromuscular diseases 2024; (11(6)):1295-1299 doi:10.1177/22143602241288400.
PMID: 39973469 - 5
Compound heterozygous mutations in MICU1 cause myopathy with extrapyramidal signs in two Chinese pedigrees.
Li J, Liu H, Gan X, et al.
Frontiers in neurology 2025; (16()):1624830 doi:10.3389/fneur.2025.1624830.
PMID: 41018190 - 6
Dolichocephaly, Arachnodactyly, Diplopia, and Distal Myopathy - Novel Phenotype of MICU1 Variant c.553C>T.
Finsterer J, Barwari A
Cureus 2024; (16(1)):e52672 doi:10.7759/cureus.52672.
PMID: 38380193 - 7
Anaesthetic management of patients with myopathies.
Schieren M, Defosse J, Böhmer A, et al.
European journal of anaesthesiology 2017; (34(10)):641-649 doi:10.1097/EJA.0000000000000672.
PMID: 28719515 - 8
Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.
Parikh S, Goldstein A, Karaa A, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(12)) doi:10.1038/gim.2017.107.
PMID: 28749475
This MPXPS information is for educational purposes only and does not constitute medical advice. Your child’s genetics and care team should tailor therapies, emergency guidance, and anesthesia precautions to their specific needs.